We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.3B
AUM Growth
+$200M
Cap. Flow
-$904M
Cap. Flow %
-5.54%
Top 10 Hldgs %
25.94%
Holding
1,279
New
291
Increased
178
Reduced
593
Closed
139

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$826M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$316M
3
AVGO icon
Broadcom
AVGO
+$129M
4
MDT icon
Medtronic
MDT
+$105M
5
DD icon
DuPont de Nemours
DD
+$84.6M

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$96M
2
MMM icon
3M
MMM
+$81.6M
3
MSFT icon
Microsoft
MSFT
+$79M
4
MRK icon
Merck
MRK
+$73.5M
5
CELG
Celgene Corp
CELG
+$65.4M

Sector Composition

Rank Sector Weight
1 Technology 17.17%
2 Healthcare 14.63%
3 Financials 13.12%
4 Communication Services 11.69%
5 Consumer Staples 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKX icon
1201
POSCO
PKX
$17.5B
-37,817
Closed -$1.77M
PLAY icon
1202
Dave & Buster's
PLAY
$357M
-465
Closed -$18K
POOL icon
1203
Pool Corp
POOL
$7.5B
-1,370
Closed -$273K
PRTA icon
1204
Prothena Corp
PRTA
$450M
-12,650
Closed -$99K
QURE icon
1205
uniQure
QURE
$3.22B
-10,100
Closed -$399K
R icon
1206
Ryder
R
$10.1B
-9,780
Closed -$503K
RARE icon
1207
Ultragenyx Pharmaceutical
RARE
$2.55B
-25,250
Closed -$1.07M
RGLD icon
1208
Royal Gold
RGLD
$19.5B
-2,762
Closed -$347K
RHP icon
1209
Ryman Hospitality Properties
RHP
$7.63B
-1,711
Closed -$140K
RIGL icon
1210
Rigel Pharmaceuticals
RIGL
$750M
-5,100
Closed -$93K
SCL icon
1211
Stepan Co
SCL
$1.48B
-373
Closed -$36K
SGMO
1212
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-73,700
Closed -$677K
SIGI icon
1213
Selective Insurance
SIGI
$5.73B
-2,900
Closed -$216K
SNV
1214
DELISTED
Synovus
SNV
-1,314
Closed -$47K
STAA icon
1215
STAAR Surgical
STAA
$1.21B
-771
Closed -$20K
SSYS icon
1216
Stratasys
SSYS
$774M
-60,000
Closed -$1.27M
SUPN icon
1217
Supernus Pharmaceuticals
SUPN
$2.77B
-40,600
Closed -$1.11M
SVC
1218
Service Properties Trust
SVC
$1.07B
-15,361
Closed -$1.98M
SWX icon
1219
Southwest Gas
SWX
$6.67B
-9,390
Closed -$845K
TBPH icon
1220
Theravance Biopharma
TBPH
$877M
-9,600
Closed -$187K
TGS icon
1221
Transportadora de Gas del Sur
TGS
$4.33B
-4,985
Closed -$40K
TNET icon
1222
TriNet
TNET
$3.14B
-2,250
Closed -$141K
TSE
1223
DELISTED
Trinseo
TSE
-1,430
Closed -$62K
TVTX icon
1224
Travere Therapeutics
TVTX
$5.78B
-15,800
Closed -$188K
TXMD icon
1225
TherapeuticsMD
TXMD
$24M
-1,430
Closed -$270K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2019 Portfolio in Review

As of Q4 2019, DekaBank Deutsche Girozentrale held 1,279 positions worth $16.3B, up 1.2% from $16.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

DekaBank Deutsche Girozentrale withdrew a net $904M in Q4 2019, closing 139 positions and reducing 593 holdings. Its most notable exit was Celgene Corp, an estimated $65.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, DekaBank Deutsche Girozentrale opened a new position in Linde worth $871M.

  • DekaBank Deutsche Girozentrale's largest Q4 2019 buy was Linde: 4,097,371 shares worth $871M.
  • DekaBank Deutsche Girozentrale added most to Phillips 66 in Q4 2019, an estimated $73.3M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2019 reduction was CME Group, cutting an estimated $96M.
  • DekaBank Deutsche Girozentrale fully exited Celgene Corp in Q4 2019, selling an estimated $65.4M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $16.3B portfolio in Q4 2019.
  • DekaBank Deutsche Girozentrale opened 291 new positions and closed 139 in Q4 2019.
  • DekaBank Deutsche Girozentrale's portfolio value rose 1.2% quarter-over-quarter to $16.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.